The QualityStocks Daily Stock List
- Blue Moon Zinc Corp. (BMOOF)
- Item 9 Labs Corp. (INLB)
- Precision Optics Corporation, Inc. (PEYE)
- Processa Pharmaceuticals, Inc. (PCSA)
- Star Navigation Systems Group Ltd. (SNAVF)
- Stereotaxis, Inc. (STXS)
- Todos Medical Ltd. (TOMDF)
- Zinc One Resources, Inc. (ZZZOF)
- Digatrade Financial Corp. (DIGAF)
- GeoVax Labs, Inc. (GOVX)
- Voip-Pal.com, Inc. (VPLM)
- The Bon-Ton Stores, Inc. (BONTQ)
- RedHawk Holdings Corp. (SNDD)
- WRIT Media Group, Inc. (WRIT)
Blue Moon Zinc Corp. (BMOOF)
NetworkNewsWire, Market Trend News, Investing News, Mining.com, Junior Mining Network, MarketSmart Resources, StreetWise Reports, TMXmoney, Small Cap Power, StockPulse, Morningstar, Geology for Investors, Market Screener, 4-Traders, Stockwatch, TradingView, Investors Hangout, and Stockhouse reported beforehand on Blue Moon Zinc Corp. (BMOOF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Blue Moon Zinc Corp. engages in the exploration and development of mineral resource properties in the U.S. It is currently is advancing its 100 percent-controlled Blue Moon zinc deposit that also contains copper, gold and silver. This project was a past producer and the Company plans to advance the Blue Moon project through to feasibility and permitting. This resource is also open at depth and along strike. Prior metallurgical testing indicates up to 95% zinc recovery with standard flotation. Blue Moon Zinc is headquartered in Vancouver, British Columbia.
The Blue Moon 43-101 Mineral Resource includes 7.8 million inferred tons at 8.07% zinc equivalent. This includes 771 million pounds of 4.95% zinc, 71 million pounds of 0.46% copper, 300,000 ounces of gold at 0.04 oz/t, and 10 million ounces of silver at 1.33 oz/t.
Regarding the Resource Update, the 2018 drill program included hole 78 that intersected 30 feet of massive sulphide mineralization grading 30.3% zinc, 1.7% copper, 1.67 g/t gold and 71 g/t silver for a ZnEq of 36.8%. This hole drilled into a previously untested area (200 feet x 500 feet) within the deposit. It represents the highest grades ever encountered at the Blue Moon property. This hole confirms the presence of thick and steeply plunging massive sulphide mineralization within the Main Zone.
In addition, Blue Moon Zinc has its Yava Property in Canada. The Yava Property is in the Mackenzie Mining District, Territory of Nunavut, roughly 450 kilometers northeast of Yellowknife. The Yava Property consists of one mining lease of 1,304 hectares and 16 unpatented mineral claims that in total cover 4,449 hectares.
Recently, Blue Moon Zinc announced the signing of a strategic joint venture (JV) where Platina Resources, Inc. (PGM.AX) can earn a 70% interest in the Blue Moon polymetallic zinc-gold-copper-silver project.
Mr. Patrick McGrath , Blue Moon Zinc's Chief Executive Officer, said, "We are very pleased to have Platina as our partner and to see the continued development and expansion of the Blue Moon project. The Joint Venture allows the Company to significantly advance the project without material dilution to current shareholders. Under the terms of the joint venture, Platina may contribute up to CAD$11.75 million in earn-in obligations and funding to the Blue Moon project in addition to direct cash payments to the Company of up to CAD$750,000.”
Blue Moon Zinc Corp. (BMOOF), closed Monday's trading session at $0.01898, up 26.5333%, on 3,000 volume with 1 trade. The average volume for the last 3 months is 8,293 and the stock's 52-week low/high is $0.009999999/$0.058499999.
Item 9 Labs Corp. (INLB)
TipRanks, Market Screener, Stockwatch, Financial Content, Stockhouse, Wallet Investor, GlobeNewswire, Financial Buzz, Invest Tribune, CannabisMarketCap, Pot Stock News, Investors Hangout, TradingView, Dividend Investor, GuruFocus, Equity Clock, Business Insider, InvestorsHub, and OTC Markets reported beforehand on Item 9 Labs Corp. (INLB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Item 9 Labs Corp. is a leader in comfortable cannabis health solutions for the modern consumer. The Company is bringing best of industry practices to markets across the nation through cultivation and production, distinct retail environments, licensing services, and diverse product suites. It caters to different medical cannabis demographics. Item 9 Labs is headquartered in Phoenix, Arizona. The Company also has it has medical cannabis operations in manifold U.S. markets.
Item 9 Labs’ asset portfolio includes Dispensary Permits, Dispensary Templates, and Strive Life. Dispensary Permits is its consulting firm. It specializes in strategic license application and compliance. Dispensary Templates, a subdivision of the firm, is a technology platform with an extensive digital library of licensing and business planning resources.
Strive Life is a turnkey dispensary model for the retail sector. It improves the patient experience with consistent and premier service, high-end design, and precision-tested products. Currently it is undergoing implementation in Arizona and North Dakota.
Item 9 Labs has also created complementary brands - Item 9 Labs and Strive Wellness - to channel consumer diversity. Propriety delivery platforms include the Apollo Vape and Pod system, as well as a pioneering intra-nasal device. Item 9 Labs has received many accolades for its medical-grade flower and concentrates. The Company’s facilities include distribution and processing operations - Strive Wellness of Ohio and Strive Wellness of Nevada, and a dispensary - Strive Life North Dakota.
This past August, Item 9 Labs reported operating results for Q3 that ended June 30, 2019. For the three months ending June 30, 2019, versus the three months ending June 30, 2018, Revenue increased 251 percent to $1,542,067. The Company had a Net Loss of $864,176.
For the nine months ending June 30, 2019 versus the nine months ending June 30, 2018, Item 9 Labs’ Revenue grew 284 percent to $3,627,951. Net Loss was $2,077,363.
Strive Grand Forks North Dakota opened on May 22, 2019 by way of a strategic partnership. Additionally, the Company completed construction and received approval to operate on Arizona expansion, more than doubling cultivation space. Moreover, construction broke ground on new corporate offices in downtown Phoenix.
Item 9 Labs Corp. (INLB), closed Monday's trading session at $2.68, even for the day, on 35 volume. The average volume for the last 3 months is 1,898 and the stock's 52-week low/high is $1.50/$8.39999961.
Precision Optics Corporation, Inc. (PEYE)
Zacks, Market Screener, AI Stock Finder, 4-Traders, GlobeNewswire, PR Newswire, BioSpace, TMXmoney, TradingView, Wallet Investor, Simply Wall St, Stockopedia, and Investing.com reported earlier on Precision Optics Corporation, Inc. (PEYE), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components. The Company provides state-of -the-art optics and optical systems for medical, biomedical, and industrial applications. Its innovative medical instrumentation line includes state-of-the-art endoscopes and endocouplers, as well as custom illumination and imaging products for use in minimally invasive surgical procedures. Precision Optics has its corporate office in Gardner, Massachusetts. The Company’s shares trade on the OTC Markets’ OTCQB.
Precision Optics’ expertise is providing lenses to sizes as small as 0.2mm in diameter using its proprietary Microprecision™ technology with the quality of ground lenses approaching the cost of gradient index (GRIN) lenses. The Company can design, prototype, and manufacture, under one roof, optical systems and components for imaging of the body's smallest compartments and tissues. Furthermore, Precision Optics has mastered the advanced techniques required to manufacture custom designed prisms. With tolerances to .01mm, it can produce a wide variety of prisms to meet clients exacting requirements.
Additionally, the Company provides optical components, optical system design and production of varied lens and prism products for the defense industry and aerospace industry. As a critical vendor, Precision Optics can assist a client’s optics development efforts from system design through volume optics fabrication and manufacturing.
The Company has been contract manufacturing OEM (original equipment manufacturer) optics components and assemblies for over three decades. Its micro optical, micro mechanical, and electro optical assembly services use Precision’s specialized techniques, tools and fixtures to assemble components in the range of 1 millimeter and smaller. Precision fabricates and assembles components, sub-assemblies, and also complete endoscopic instruments.
Precision Optics announced this past July that it completed the acquisition of certain assets of Ross Optical Industries, Inc., a privately-held company based in El Paso, Texas. The acquisition extends Precision Optics’ product offering to include a wider array of lens and optical system sizes. The acquisition also increases Precision’s presence in the U.S. defense sector.
Recently, Precision Optics announced operating results on an unaudited basis for its Q4 and Fiscal Year (FY) ended June 30, 2019. Selected highlights include Revenue for the quarter was $2.4 million versus $1.5 million in the same quarter of the prior fiscal year. This represents an increase of 63 percent driven chielfy by an increase in Production Revenue for medical devices, which incorporate Precision's Microprecision™ technology, and also one month of contribution from Ross Optical.
Revenue for the fiscal year (ended June 30, 2019) was $6.8 million versus $4.0 million in the prior fiscal year. This represents an increase of 69 percent.
Precision Optics Corporation, Inc. (PEYE), closed Monday's trading session at $1.64, off by 3.5294%, on 10,322 volume with 4 trades. The average volume for the last 3 months is 17,852 and the stock's 52-week low/high is $0.800000011/$1.84000003.
Processa Pharmaceuticals, Inc. (PCSA)
Zacks, Simply Wall St, TradingView, Stockopedia, Stockhouse, TMXmoney, Street Insider, Biospace, Last10k, Financial Buzz, OTC Markets, PR Newswire, Infront Analytics, Stockwatch, GlobeNewswire, Market Screener, and Finance Recorder reported earlier on Processa Pharmaceuticals, Inc. (PCSA), and today we report on the Company, here at the QualityStocks Daily Newsletter.
A clinical stage biopharmaceutical company, Processa Pharmaceuticals, Inc. is developing products to improve the survival and/or quality of life for patients who have a high unmet medical need condition. It has assembled a proven regulatory science development team, management team, and Board of Directors. The Processa team has been involved with more than 30 drug approvals by the FDA (Food and Drug Administration), including drug products targeted to orphan disease conditions, and 100 FDA meetings. Established in 2017, Processa Pharmaceuticals is based in Hanover, Maryland and the Company lists on the OTC Markets Group’s OTCQB.
PCS-499 represents the first Processa Pharmaceuticals drug that can potentially be used in several unmet medical need conditions. The Processa process is to develop drugs that are ready for clinical development or have minimal pre-IND enabling studies to complete. Processa acquires drugs that already have some clinical data to support the targeted treatment. This is whether it be the drug itself, an analog of the drug, or a drug with like pharmacological targets.
Furthermore, the Company navigates through the FDA, collaborating with the reviewers to define a complete development program. Processa develops each drug over 2-4 years, out-licensing the drug either just before pivotal study after Phase 2b or just after the completion of the pivotal study.
Lead product PCS-499 will be investigated for the treatment of Necrobiosis Lipoidica. This is a necrotizing skin condition caused by several pathophysiological changes. A second unmet medical need under investigation is the use of PCS-499 to treat radiation-related adverse effects in head & neck cancer. For both indications there are no FDA approved treatments. Moreover, the current standard of care is not sufficient for patients.
Last month, Processa Pharmaceuticals announced that it signed an exclusive worldwide license agreement with Akashi Therapeutics. This is to develop and commercialization Akashi’s lead drug, HT-100. HT-100 is an orally available anti-fibrotic, anti-inflammatory drug that also promotes healthy muscle fiber regeneration.
Processa Pharmaceuticals plans to commence developing HT-100 in rare adult fibrotic related diseases such as focal segmental glomerulosclerosis (FSGS), idiopathic pulmonary fibrosis (IPF) or Scleroderma, where there are still few therapeutic options. It will revisit potential pediatric indications, such as Duchenne Muscular Dystrophy (DMD), at a later time.
Dr. Sian Bigora, Chief Development Officer at Processa Pharmaceuticals, said, “Processa needs to learn more about the safety and dose response of HT-100 while we determine the best way to clinically manage patients on this anti-fibrotic drug. In early 2020 we hope to begin to define, in collaboration with the FDA, an efficient way to develop HT-100 for all those patients who would benefit from this drug.”
Processa Pharmaceuticals, Inc. (PCSA), closed Monday's trading session at $2.50, even for the day, on 2,000 volume. The average volume for the last 3 months is 485 and the stock's 52-week low/high is $1.50/$4.1999998.
Star Navigation Systems Group Ltd. (SNAVF)
Hot Stocked, GuruFocus, Research Pool, Micro Small Cap, Nasdaq, InvestorX, Street Insider, Wallet Investor, TMXmoney, Morningstar, 4-Traders, TradingView, Stockhouse, GlobeNewswire, and InvestorsHub reported previously on Star Navigation Systems Group Ltd. (SNAVF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Star Navigation Systems Group Ltd. owns the exclusive international license to its proprietary, patented In-flight Safety Monitoring System, STAR-ISMS®, the core of the STAR-A.D.S. ® and of the STAR-ISAMM™ Systems. The Company develops, markets, and promotes In-Flight Safety Monitoring Systems (ISMS) globally. Its real-time capability of tracking performance trends and predicting incident-occurrence enhances aviation safety and improves fleet management. It does so while lessening costs for the operator. Star Navigation Systems has its corporate headquarters in Brampton, Ontario.
The OTCQB-listed Company’s subsidiary, Star-Isoneo, Inc., is a specialized software firm. Star-Isoneo develops complex solutions in engineering, simulation and development for Canadian customers. Star-Isoneo works closely with Star Navigation Systems in the development of the Company’s MEDEVAC (STAR-ISAMM™ and STAR- LSAMM™) applications of the patented STAR-A.D.S. ® technology, and on its present research and development (R&D) program with Bombardier, Inc.
Star Navigation’s M.M.I. Division designs and manufactures high performance, mission critical, flight deck flat panel displays for defence and commercial aviation industries worldwide. For example, these displays are found on aircraft and simulators, from C-130 aircraft, to Sikorsky and Agusta Westland helicopters.
Star Navigation Systems (with capabilities in Flat Panel Displays) provides its customers, OEMs (original equipment manufacturers) and operators, advanced, reliable and proven technologies to modernize their aircraft, helicopters and other vehicles. Star’s technologies support commercial and military aviation, search and rescue operations, and naval applications.
Concerning Medical Evacuation Vehicles, applied to Emergency Medical Services vehicles and environment and MEDEVAC platforms, STAR-A.D.S.™ will ensure real time transmission of critical bio data for speedier and safer dispatch and support to patients. In addition, pertaining to Commercial and Military Aircraft: STAR-A.D.S.™, embedded in the Company’s systems, is global real time tracking for safer aircraft operations, and meeting today the recommendations of ICAO, IATA, and the NTSB for the future of Aircraft Tracking and Safety.
In September, Star Navigation Systems announced that it entered into a partnership and industrial agreement with ANTAZ Technologies Pvt. Ltd, (Antaz). Antaz is a well-established Indian company with facilities in Hyderabad, Bangalore and Delhi, India. Antaz will adapt, integrate, as well as market Star Navigation Systems products to the Indian Defence Forces (Air Force and Navy) in collaboration with Hindustan Aeronautics Limited (HAL). Star is already listed as a registered supplier to HAL for military equipment.
Last week, Star Navigation Systems announced the granting of a new Supplemental Type Certification (STC) to the Company by Transport Canada. The STC relates to the use of the STAR-A.D.S. ® Gen 3 system on an Airbus A320 aircraft type. The STC will allow Star Navigation to install its STAR-A.D.S. ® Gen 3 System on-board the next available AlMasria Universal Airlines aircraft.
Viraf Kapadia, Star Navigation Systems’ Chief Executive Officer, said, “This additional STC adds to our growing list of certifications for commercial and business aircraft. We already had an STC for the previous STAR-A.D.S. ® Gen 2 model. Now the Gen 3 is also A 320 certified and we can offer even more flexibility to an operator, adding GSM communications and manual retrieval through USB port.”
Star Navigation Systems Group Ltd. (SNAVF), closed Monday's trading session at $0.0248, even for the day. The average volume for the last 3 months is 3,243 and the stock's 52-week low/high is $0.017/$0.0643.
Stereotaxis, Inc. (STXS)
NetworkNewsWire, StockTwits, Zacks, Insider Financial, Equities, 4-Traders, Proactive Investors, EarningsCast, Market Screener, Simply Wall St, Equity Clock, GuruFocus, MarketWatch, YCharts, Wallet Investor, Insider Tracking, InvestorsHub, Stockhouse, and Barchart reported previously on Stereotaxis, Inc. (STXS), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Stereotaxis, Inc. is the international leader in unique robotic technologies for the treatment of cardiac arrhythmias. The design of these robotic technologies are to enhance the treatment of arrhythmias and perform endovascular procedures. Greater than 100 issued patents support the Stereotaxis platform. The core components of the Company’s systems have received regulatory clearance in the United States, Canada, the European Union (EU), Japan, China, and elsewhere. Stereotaxis is based in St. Louis, Missouri.
Stereotaxis’ mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide first-class patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The Company’s core Epoch™ Solution includes the Niobe® ES remote magnetic navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems, and the Vdrive™ robotic navigation system and consumables.
Stereotaxis provides increased efficacy and efficiency in combination with a first-in-class safety profile in ventricular arrhythmias, congenital procedures, and certain other special situations. The validation of the value provided in these procedures is in the fact that many leading hospitals have adopted Stereotaxis for all of their ventricular procedures and have seen major growth following adoption of the technology.
This past June, Stereotaxis announced the first graduating class from its Robotic Electrophysiology Fellows Program. The design of the Robotic Electrophysiology Fellows Program is to enhance the traditional electrophysiology fellowship through facilitating mastery of robotic magnetic navigation, fostering a worldwide community of the future leaders in the field, and providing fellows with a differentiated and specialized skillset as they advance their medical careers. The Robotic Electrophysiology Fellows Program (established in 2018) is currently active at 18 leading medical centers worldwide and has enrolled 34 electrophysiology fellows.
Recently, Stereotaxis announced that Ms. Kimberly Peery was appointed Stereotaxis Chief Financial Officer (CFO), effective October 1, 2019. Ms. Peery joined Stereotaxis in 2003. She presently serves as Vice President of Finance. Before Stereotaxis, she served as a Controller at different private companies. Ms. Peery is a Certified Public Accountant. She earned a Bachelor of Science in Accounting and Master of Science in Accounting and Computer Science from Southern Illinois University, Edwardsville.
Stereotaxis, Inc. (STXS), closed Monday's trading session at $3.22, off by 3.5928%, on 136,420 volume with 393 trades. The average volume for the last 3 months is 116,000 and the stock's 52-week low/high is $1.00/$4.75.
Todos Medical Ltd. (TOMDF)
Stock Day Media, Stock News Now, Biospace, TalkMarkets, InvestorsHub, Investors Hangout, Stockhouse, Otc.watch, Wallet Investor, TradingView, GlobeNewswire, Dividend Investor, Market Screener, Stockopedia, Proactive Investors, and TipRanks reported beforehand on Todos Medical Ltd. (TOMDF), and we also report on the Company, here at the QualityStocks Daily Newsletter.
Todos Medical Ltd. centers on the development of blood tests for the early detection of cancer and neurodegenerative disorders, such as Alzheimer's disease (AD). It does so via Breakthrough Diagnostics, Inc., its joint venture (JV) with Amarantus Bioscience Holdings, Inc. Breakthrough Diagnostics is developing the Alzheimer’s blood diagnostic LymPro Test®. A clinical-stage in-vitro diagnostic company, Todos Medical is headquartered in Rehovot, Israel. The Company lists on the OTCQB.
Todos Medical has developed two cancer screening tests based on TBIA (Todos Biochemical Infrared Analyses). This is a method for cancer screening utilizing peripheral blood analysis. The TBIA screening method is based on the cancer’s influence on the immune system, which triggers biochemical changes in peripheral blood mononuclear cells and plasma. The proprietary and patented method incorporates biochemistry, physics, and signal processing.
Todos Medical’s TBIA platform represents a cost effective, scalable, and patient friendly screening method for cancer screening. The TBIA method is a proprietary method for the screening of solid tumours employing peripheral blood spectroscopy analysis. The process involves observing the immune system’s response to tumor presence instead of looking for the tumor cells themselves or specific markers. TBIA analyzes the whole biochemical signatures spectrum (including proteins, lipids, nucleic acids and carbohydrates) of effected immune cells from peripheral blood, utilizing infrared spectroscopy.
The Company’s two cancer screening tests, TM-B1 and TM-B2, have received the CE mark. Todos’ new cancer test will add a layer to currently available cancer screening and diagnostics. Todos’ technology is a platform. The Company is investigating methods for using its platform on other types of cancers. Initially, Todos Medical is focusing on breast and colon cancers.
In September, Todos Medical announced that it entered into a binding term sheet with HWH World Pte Ltd., a wholly-owned subsidiary of Singapore eDevelopment (40V.SI) for the grant of exclusive marketing rights for Todos’ TM-B1 and TM-B2 tests to HWH World’s network of members in Singapore, Malaysia, the Philippines, Vietnam, Thailand, Indonesia, South Korea, Hong Kong, China, the USA and Canada. HWH World is a marketing firm that concentrates on health and wellness. HWH World will work closely with Todos Medical to attain regulatory approval in Singapore, where Todos Medical recently completed clinical studies, and afterward expand into other markets.
Additionally, in September, Todos Medical and Orot+, the operational division of Orot-Luces, which executed a distribution agreement with Todos for the commercial distribution of Todos’ TM-B1 and TM-B2 blood screening tests for breast cancer, announced the enrollment of the first patient in the pre-commercial launch study of TM-B1 and TM-B2 in Europe. The expectation is that the pre-commercial launch study will last about 6 months.
Upon completion of the pre-commercial launch study, the expectation is that TM-B1 and TM-B2 will be available for commercial sale in Romania by Orot. Orot is providing full funding for the pre-commercial launch study and also the commercial launch in accordance with the terms of the exclusive distribution agreement.
Todos Medical Ltd. (TOMDF), closed Monday's trading session at $0.16, even for the day, on 28,404 volume with 10 trades. The average volume for the last 3 months is 17,956 and the stock's 52-week low/high is $0.05/$0.340000003.
Zinc One Resources, Inc. (ZZZOF)
NetworkNewsWire, 4-Traders, MarketWatch, YCharts, InvestorX, InvestorsHub, Market Screener, Wall Street Profiler, Streetwise Reports, InvestorIntel, Stock of the Week, Epic Stock Picks, All Penny Stocks, Stockhouse, Dividend Investor, Insider Financial, Marketwired, Investing News, Barchart, StockInvest, Wallet Investor, Investor Ideas, and Investors Hangout reported previously on Zinc One Resources, Inc. (ZZZOF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Zinc One Resources, Inc. concentrates on the acquisition, exploration and development of prospective and advanced zinc projects in mining-friendly jurisdictions. Its key assets are the past producing Bongará Zinc Mine Project and the Charlotte-Bongará Zinc Project in Peru. The Company formerly went by the name Rockridge Capital Corp. It changed its corporate name to Zinc One Resources, Inc. in January 2017. Zinc One Resources is based in Vancouver, British Columbia.
The Company acquired Forrester Metals, Inc. in June of 2017. As a result, it acquired the Bongará Mine and Charlotte-Bongará Projects. Both host high-grade, nonsulphide zinc mineralization at or near the surface. At the Bongará Zinc Mine the mineralization is concentrated along and proximal to a NW – trending anticlinal axis over approximately 2.5 kilometers.
The Bongará Zinc Mine was mined in 2007 and 2008 by a previous owner by open-pit methods, dried at the site, and then shipped 540 kilometers westward to the coast where it was processed via a Waelz kiln. This is a processing technology usually applied to flue dust from steel mills to recover zinc. In August 2008, the mine was closed down mainly due to a drop in the price of zinc at that time.
The exploration upside at Charlotte-Bongará includes greater than 8,000 meters of drilling. This includes results of 29.5% Zn across 15.5 meters, 26.1% Zn across 12.5 meters, and 29.7% Zn across 11.5 meters.
Zinc One Resources previously announced the first National Instrument 43-101 (NI 43-101) Mineral Resource estimate for its Bongará Zinc Mine project in north-central Peru. Watts Griffis and McOuat Limited (WGM) prepared the estimate for the Company. A supporting NI 43-101 technical report will be available under Zinc One Resources’ profile on SEDAR at www.sedar.com and on the Company's website at www.zincone.com within 45 days of this release (dated February 5, 2019).
Recently, Zinc One Resources announced the results of voting at the Company’s Annual General Meeting (AGM) of shareholders that took place on March 13, 2019, in Vancouver, British Columbia. Shareholders at the AGM approved all matters. This included the appointment of the four incumbent directors - Dr. William C. Williams, Mr. Barry Girling, Mr. Greg Crowe, and Mr. Gunther Roehlig, for the following year, the re-appointment of Charlton & Co. LLP as auditors of Zinc One Resources, and the renewal of the Company's 10 percent rolling stock option plan.
Zinc One Resources, Inc. (ZZZOF), closed Monday's trading session at $0.0151, up 63.2432%, on 227 volume with 1 trade. The stock's 52-week low/high is $0.000099999/$0.090300001.
Digatrade Financial Corp. (DIGAF)
MarketWatch, Bloomberg, InvestorsHub, and The Wall Street Journal reported on Digatrade Financial Corp. (DIGAF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Digatrade Financial Corp. is a global digital asset exchange and blockchain development services company. It engages in the licensing, development, and branding of a digital exchange trading platform and a peer to peer electronic payment processing network for enabling users to trade fiat and alternative currencies. Basically, DIGATRADE is a Digital Asset, Currency (Bitcoin) Exchange, and Internet Financial Services Company owned and operated by Digatrade Financial Corp.
Digatrade Financial is based in Vancouver, British Columbia. Formed in 2000, the Company lists on the OTC Markets Group’s OTCQB. It previously went by the name Bit-X Financial Corporation. It changed its name to Digatrade Financial Corp. in October of 2015.
Digatrade Financial provides operational support specializing in web-based digital currency exchange and transaction services for the cryptographic digital currencies. This includes Bitcoin and other alternative digital coins. The Company provides a user-friendly, secure, and affordable platform to purchase and sell Bitcoin and other digital assets. Digatrade provides a 24-hour online platform. This platform provides the automated matching of orders between its registered members.
The proprietary Digatrade trading and matching engine manages high volume, high throughput, and low latency trading. Furthermore, this engine features blended multi-currency settlement in addition to real time FX pricing and risk management fully powered by ANX Technologies. The order engine delivers pre-scan indicative pricing. Users can choose to either fix the quantity of Bitcoins or fix the price paid for every order.
Digatrade Financial announced in April 2017, the execution of a definitive agreement with No Limits Consulting Ltd. (d/b/a: ANX International, ANX Technologies & ANXPRO) based in Hong Kong. Under new financial terms, Digatrade has re-positioned itself to continue its development with its core digital asset exchange platform. This is while centering on the implementation of new Initial Digital Offerings (IDO's) for institutional customers, marketing, and brand awareness.
Digatrade has launched the Digatrade OTC Trade Desk. The new Digatrade Over-the-Counter (OTC) trading service will let KYC verified customers to complete trades outside the online liquidity order book at competitive market prices.
At present, Digatrade Financial is developing a number of new technologies for the Digatrade Core 2.0 Digital Asset Trading Platform. In addition, the Company is seeking more new opportunities and partners for growth as Bitcoin (BTC) continues to grow in value with a market capitalization now surpassing $23.5 Billion.
Digatrade Financial Corp. (DIGAF), closed Monday's trading session at $0.0027, up 50.00%, on 20,007,244 volume with 69 trades. The average volume for the last 3 months is 3,411,149 and the stock's 52-week low/high is $0.001/$0.024399999.
GeoVax Labs, Inc. (GOVX)
StreetWise Reports, Zacks, Street Insider, Investor Village, Stock News Now, Micro Cap Daily, OTC Markets, Stockwatch, Marketbeat, Real Investment Advice, InvestorsHub, Stockhouse, and Proactive Investors reported previously on GeoVax Labs, Inc. (GOVX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, GeoVax Labs, Inc. is a biotechnology company developing human vaccines. The Company is developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. GeoVax Labs current development programs are centered on preventive vaccines against HIV, Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa), and malaria, and also therapeutic vaccines against chronic Hepatitis B infections and numerous cancers. GeoVax Labs has its head office in Smyrna, Georgia.
MVA is a large virus capable of carrying a number of vaccine antigens. On the platform, MVA expresses proteins that assemble into VLP immunogens within (in vivo) the person receiving the vaccine. The production of VLPs in the person being vaccinated mimics virus production in a natural infection, stimulating the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. The MVA-VLP derived vaccines elicit durable immune responses in the host alike to a live-attenuated virus. This is while providing the safety characteristics of a replication-defective vector.
GeoVax Labs has designed the leading preventative HIV vaccine candidate to fight against the subtype of HIV predominant in the larger commercial markets of the Americas, Western Europe, Japan, and Australia. At present, this program is undergoing human clinical trials managed by the HIV Vaccine Trials Network (HVTN) with the support of the National Institutes of Health (NIH).
Additionally, the Company’s HIV vaccine is part of collaborative efforts to develop an immunotherapy as a functional cure for HIV. Last week, GeoVax Labs announced its observance of HIV Vaccine Awareness Day on May 18, 2019. HIV Vaccine Awareness Day is observed each year to recognize the many volunteers, community members, health professionals, and scientists working to develop a vaccine to prevent HIV. Furthermore, it is an opportunity to educate communities about the importance of preventive HIV vaccine research.
Recently, GeoVax Labs announced that it will be engaged in corporate partnering meetings during the BIO International Convention, to take place in Philadelphia, Pennsylvania on June 3-6, 2019. The Company was selected by the National Institutes of Health (NIH) and BIO to exhibit and showcase its technology in a high-profile area of the exhibition floor branded as the Innovation Zone, dedicated to recipients of NIH SBIR/STTR grants.
GeoVax Labs, Inc. (GOVX), closed Monday's trading session at $0.0027, up 42.1053%, on 52,257,646 volume with 400 trades. The average volume for the last 3 months is 3,750,086 and the stock's 52-week low/high is $0.001799999/$3.58999991.
Voip-Pal.com, Inc. (VPLM)
SmallCapVoice, SmallCapAllStars, FeedBlitz, TheSUBWAY, Stock Twiter, Pumps and Dumps, Equities, VC Stock Marketing, Clutch Investments, Equities Canada, TryBestPennyStocks, Buzz Stocks, and UndiscoveredEquities reported on Voip-Pal.com, Inc. (VPLM), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Voip-Pal.com, Inc. owns a portfolio of patents relating to Voice-over-Internet Protocol (VoIP) technology. The OTCQB-listed Company is now looking to monetize its fundamental patents by way of a sale or licensure of its technology. In December 1997, Voip-Pal.com incorporated in the State of Nevada. In 2013, it acquired Digifonica International (DIL) Limited to fund, co-develop, and complete Digifonica's patent collection. Voip-Pal.com has its corporate office in Bellevue, Washington.
Voip-Pal’s Intellectual Property (IP) value comes from manifold issued US Patent and Trademark Office (USPTO) patents. This includes five parent patents, one of which is foundational and the others that build upon the former. The five core patents are: Routing, Billing & Rating (RBR); Lawful Intercept; Enhanced E-911; Mobile Gateway; and Uninterrupted Transmission.
Voip-Pal.com’s patented technology provides Universal numbering ubiquity; network value as defined by Metcalfe; the imperative of interconnect, termination, and recompense for delivery of calls by other networks; and regulatory compliance in regulated markets. Additionally, the Company’s patented technology provides interconnection of VoIP networks to mobile and fixed networks; and maintenance of uninterrupted VoIP calls across fixed, mobile, and Wi-Fi networks.
Voip-Pal believes that its Lawful Intercept patents could prove to be a vital tool for law enforcement in its efforts to combat crime and stop terror attacks. The technology provides the means for judicially authorized covert intercept of any kind of communications sent through VoIP. This includes voice calls, media, as well as messaging.
The Company’s U.S. patent portfolio has grown from five core patents to 20 issued patents or allowed applications, and a number of pending patent applications in different stages of examination at the USPTO. The most recent addition to the U.S. patent portfolio is U.S. Patent No. 9,998,363, issued June 12, 2018. It relates to allocating charges for communications services. Also, Voip-Pal owns issued patents and/or pending patent applications in Canada, Europe, India, Indonesia, and Brazil. On May 30, 2018, Voip-Pal was granted European Patent No. 2,084,868 for its communications/routing technologies.
Voip-Pal.com, Inc. (VPLM), closed Monday's trading session at $0.0254, up 33.9662%, on 4,051,974 volume with 89 trades. The average volume for the last 3 months is 839,875 and the stock's 52-week low/high is $0.009999999/$0.094999998.
The Bon-Ton Stores, Inc. (BONTQ)
Penny Stock Hub, Zacks, Stockopedia, Investor Place, Investing.com, Stockflare, 4-Traders, InvestorsHub, StreetInsider, YCharts, Barchart, Stockhouse, and TradingView reported on The Bon-Ton Stores, Inc. (BONTQ), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTC Markets Group’s OTCQB and established in 1898, The Bon-Ton Stores, Inc. operates 250 stores. These include nine furniture galleries, in 23 states in the Northeast, Midwest and upper Great Plains under the Bon-Ton, Bergner's, Boston Store, Carson's, Elder-Beerman, Herberger's and Younkers nameplates. The Bon-Ton Stores has corporate headquarters in York, Pennsylvania and Milwaukee, Wisconsin.
The Company’s stores offer a wide variety of national and private brand fashion apparel and accessories for women, men and children. The stores also offer cosmetics and home furnishings.
The Bon-Ton Stores has been taking action over the past number of months to boost improved performance and strengthen its financial position. The Company has taken another step forward in its efforts through filing voluntary petitions for a court-supervised restructuring under Chapter 11.
On February 4, 2018, The Bon-Ton Stores, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Its varied stores throughout the U.S. are open. In addition, its e-commerce and mobile platforms are operating normally.
Recently, The Bon-Ton Stores announced that it received a signed letter of intent (LOI) from an investor group consisting of DW Partners, Namdar Realty Group (including its partner Mason Asset Management) and Washington Prime Group. This investor group proposes to acquire The Bon-Ton Stores as a going concern in a Bankruptcy Court-supervised sale process.
The Bon-Ton Stores and this investor group are in the process of finalizing an asset purchase agreement in advance of an auction. The auction is now scheduled to be held on Monday, April 16, 2018.
Mr. Bill Tracy, The Bon-Ton Stores’ President and Chief Executive Officer, said, "We are pleased to have received this signed letter of intent and are advancing our discussions with the investor group to complete an asset purchase agreement as we proceed toward the court-supervised auction. With the help of our advisors, we will evaluate all qualified bids and are committed to maximizing value and pursuing the best path forward for the Company and our stakeholders.”
The Bon-Ton Stores, Inc. (BONTQ), closed Monday's trading session at $0.018, up 125.00%, on 19,147 volume with 11 trades. The average volume for the last 3 months is 6,963 and the stock's 52-week low/high is $0.0026/$0.076999999.
RedHawk Holdings Corp. (SNDD)
TopPennyStockMovers, Real Pennies, Greenbackers, Fast Money Alerts, Mad Money Picks, The Observer, Innovative Marketing, Penny Stock General, Stock Shock and Awe, PennyStocks24, and Hot Stock Profits reported earlier on RedHawk Holdings Corp. (SNDD), and we also report on the Company, here at the QualityStocks Daily Newsletter.
RedHawk Holdings Corp. is a diversified holding company listed on the OTC Markets. The Company, via its subsidiaries, engages in the sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services. RedHawk Holdings was formerly Independence Energy Corp. RedHawk’s subsidiaries are RedHawk Medical, EcoGen Europe, RedHawk Energy Corp., and RedHawk Land & Hospitality. RedHawk Holdings is based in Louisiana.
RedHawk Energy holds the exclusive U.S. manufacturing and distribution rights for the Centri Controlled Entry System. This System is a unique, closed cabinet, nominal dose transmission full body x-ray scanner.
Through its RedHawk Medical Products business unit, RedHawk Holdings sells WoundClot Surgical - Advanced Bleeding Control; the Sharps and Needle Destruction Device (SANDD™); the Carotid Artery Digital Non-Contact Thermometer, and Zonis®.
RedHawk Medical Products UK Limited is a specialist medical device company. It delivers innovative product solutions to healthcare markets in the United Kingdom (UK), Europe and the Middle East.
EcoGen Europe’s dedication is to healthcare and the NHS. Its commitment is to securing savings across the drug budget in primary care. This is while providing innovation to drive patient care in the acute setting. Last month, RedHawk Holdings announced that it recently completed its financial and legal due diligence and upon execution of final agreements, it will increase its ownership interest in EcoGen Europe to 75 percent.
RedHawk’s financial services revenue is from brokerage services earned in association with debt placement services and investments in oil and gas exploration and production. The Company’s real estate leasing revenues come from varied commercial properties under long-term lease. Moreover, its real estate investment unit holds limited liability company interest in different commercial restoration projects in Hawaii.
EcoGen Europe has signed an exclusive agreement to license and supply a new non-patent infringing generic spray formulation of Sildenafil Citrate in the UK. EcoGen will market the new spray under the brand name Azulvig. EcoGen expects to start marketing Azulvig after receipt of final UK regulatory approval.
RedHawk Holdings has acquired a stake in Tigress Energy Partners. RedHawk agreed to acquire up to a 25 percent interest in Marlin USA Energy Partners, LLC, the minority owner of Tigress Energy Partners, LLC (TEP). The majority ownership of TEP is held by Tigress Holdings, LLC, a limited liability company majority-owned by Cynthia DiBartolo, Chief Executive Officer of Tigress Financial Partners LLC (TFP).
RedHawk Holdings has also completed the re-engineering of its Sharps and Needle Destruction Device (SANDD). It received pre-market clearance from the U.S. Food and Drug Administration (FDA) for the sale of SANDD in the U.S. RedHawk Medical Products acquired the tangible and intangible property rights to SANDD (formerly known as the Disintegrator™ Insulin Needle Destruction Unit) in December 2015.
In early August, RedHawk Holdings announced that its wholly-owned real estate subsidiary, RedHawk Land & Hospitality LLC, entered into new agreements for the lease of its two commercial properties in Lafayette, Louisiana. The Company said it entered into a new triple-net lease agreement with the Louisiana 3rd Circuit Court of Appeal to renew and extend the present lease term to December 31, 2022. The new lease agreement was effective August 1, 2017 and included certain rate increases.
RedHawk Holdings Corp. (SNDD), closed Monday's trading session at $0.0142, off by 9.3231%, on 3,090,942 volume with 99 trades. The average volume for the last 3 months is 13,724,647 and the stock's 52-week low/high is $0.000799999/$0.017899999.
WRIT Media Group, Inc. (WRIT)
SeriousTraders, Tip.us, Real Pennies, StocksToBuyNow, Pennystockmania, Great Penny Picks, and SmallCapVoice reported earlier on WRIT Media Group, Inc. (WRIT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
WRIT Media Group, Inc. is a diversified media and software business whose shares trade on the OTC Markets. The Company’s portfolio of wholly-owned businesses includes Front Row Networks; Amiga Games; Retro Infinity, Inc.; and Pandora Venture Capital. WRIT Media Group is headquartered in Los Angeles, California.
WRIT Media’s operations include digital currency software development, including trading platforms and Blockchain solutions, content production and distribution; and video game distribution by way of mobile platforms. Its Front Row Networks produces and distributes live event programming for international digital broadcast to movie theaters and online streaming.
WRIT’s Amiga Games is a software company. Amiga is restarting the Amiga brand through publishing retro video games on smartphones and tablets. WRIT’s Retro Infinity is a video game distribution site. It publishes video games from Amiga, Atari and other "retro" brands on contemporary smartphones, tablets and consoles.
Additionally, WRIT’s Pandora Venture Capital is a financial technology company. Pandora has an emphasis on its digital currency, Pelecoin, a new generation of digital currency, Blockchain technology solutions, and also the CrypFXPro trading platform. WRIT Media's proprietary CrypStock digital trading platform will provide the technology that will support the creation and trading platform for Pelecoin and other digital currencies.
WRIT Media Group plans to integrate its Pelecoin Blockchain technology into products and applications that can be used to make it as easy to spend digital currencies, cryptocurrencies, and Pelecoin, as it is to spend US Dollars. Through the Company’s acquisition of Pandora Venture Capital, WRIT assumed a skilled management team with backgrounds in payments, telecom, and digital currency.
Recently, WRIT Media Group announced a number of technology innovations within its Pelecoin cryptocurrency system. The Company plans over the next year to enhance its software platform through adding more features and by expanding its ecosystem through new products.
WRIT Media's development team has also recently built the core functionality of its digital currency system. The Company now offers a new feature that enables users to mine four cryptocurrencies at the same time by employing Pelecoin's proprietary mining algorithm software. The core system is complete. The foundation is ready for Pelecoin to expand and become a strong platform suitable for broader adoption, with updated core features and extensive new ones for its ecosystem.
WRIT Media Group, Inc. (WRIT), closed Monday's trading session at $0.02, up 53.8462%, on 9,102 volume with 3 trades. The average volume for the last 3 months is 4,094 and the stock's 52-week low/high is $0.009999999/$0.05395.
The QualityStocks Company Corner
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- SinglePoint, Inc. (SING)
- Neutra Corp. (OTCQB: NTRR)
- GP Solutions (OTC: GWPD)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Trxade Group Inc. (TRXD)
- Geyser Brands Inc. (TSX.V: GYSR)
- HTC Extraction Systems (TSX.V: HTC)
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)
- CloudCommerce (OTCQB: CLWD)
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
It would have been almost impossible to predict, just a few years ago, how big the cannabis space would be by now. Recent legislative decisions from both the United States and Canadian governments have led to a booming industry, one that supports dozens of companies vying for a share of cannabis profits. The recent downturn in the market, however, shows that not every company will survive the industry’s infancy and prove profitable in the long run. Investors need to consider which cannabis and CBD companies have plans to establish themselves as broadly and as firmly as they can, particularly in the retail sector. Companies that are implementing these plans—like Green Growth Brands Inc. (CSE:GGB) (OTC:GGBXF).
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed Monday's trading session at $1.29, up 13.1579%, on 479,772 volume with 499 trades. The average volume for the last 3 months is 366,183 and the stock's 52-week low/high is $0.843599975/$5.20499992.
- Growth in the Cannabis Industry Coming Through Ambitious Expansion and Big-Name Partnerships
- Green Growth Brands Opens 150th CBD Shop and Provides Progress Update
- AI Analytics Report Reveals Drivers of the CBD Craze
SinglePoint, Inc. (SING)
SinglePoint, Inc. (SING) was featured today in a publication from CBDWire, examining how epilepsy is one of those diseases there’s no coming back from. Once diagnosed, the best you can do is find suitable ways to cope with it. It’s even more challenging if your little one is afflicted, and it can have a tremendous impact on the families affected. While there is currently no cure for epilepsy, there’s a host of anti-seizure meds that can reduce the frequency of the seizures and give the child a healthier life.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Monday's trading session at $0.01127, up 0.625%, on 2,467,571 volume with 81 trades. The average volume for the last 3 months is 3,062,396 and the stock's 52-week low/high is $0.009999999/$0.035999998.
- Australian Trial Shows CBD Gel Reduces Seizures in Epileptic Kids
- SinglePoint, Inc. (SING) CEO Reports from NACS Tradeshow on MoneyTV with Donald Baillargeon
- 420 with CNW – FBI Data Shows Cannabis Arrests Increased Last Year
Neutra Corp. (OTCQB: NTRR)
Early-stage research and development company Neutra Corp. (OTCQB: NTRR)today announced that its subsidiary VIVIS Corp. is rapidly approaching the market release of a new transdermal, hemp-based sports cream. To view the full press release, visit http://cnw.fm/Ca4xU.
Neutra Corp. (OTCQB: NTRR) is an early-stage research and development company bringing modern healthy living solutions to a multi-billion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture – one where consumers are demanding access to products that promote health and stave off potential health dangers.
Neutra is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Hemp-based CBD consumer products generated sales of up to $390 million in 2018 with projections pointing to a $3 billion market by 2022, according to the Hemp Business Journal.
Neutra’s new broadened scope, which includes the commercialization of newer, more effective products, aims to capitalize on this worldwide boom. Our company is seeking new and exciting opportunities that can accelerate Neutra’s mission to bring these products to a wider demographic. Our work reflects a renewed dedication to supporting a better body, environment and life for people around the globe.
- Vivis – Neutra is expanding its market presence in the rapidly growing hemp-derived CBD market with a letter of intent to acquire Vivis, an emerging retail brand of hemp-based health and nutritional products. Vivis’ hemp-derived CBD products are third-party certified as contaminant-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With Vivis as the new retail face of Neutra, the company is expecting greater interest in its expanding portfolio of branded products moving to market.
- J3 Holdings – The signing of a letter of intent to acquire J3 Holdings includes the company’s land and warehouse, as well as a license to cultivate hemp and refine it into usable forms. Neutra has concentrated its early efforts developing business networks and on developing hemp-based CBD products, including supplements and creams. The latest move will enable the company to grow its own hemp supply, giving it more control over the quality of its ingredients.
- Surface to Air Solutions is the North American distributor of a patent-pending, water-based solution known as Purteq, a green technology that works similar to photosynthesis.
- ZeroBlast uses a durable, non-toxic, anti-microbial solution to eliminate all contaminates and kill germs on contact for a period of up to 90 days.
Neutra president and CEO Sydney Jim provides strong executive leadership, a network of business contacts and experience implementing solid corporate strategy. Jim has a proven track record of adding value for public company shareholders. He founded Global Visionary Investments where operational support is provided to seven different companies and their subsidiaries. Jim was also the CEO of First Titan Energy, a microcap public company where he was responsible for restructuring the corporate structure, deal sourcing, and leading the company in mergers and acquisitions.
Dr. Scott Cherry is the company’s sports performance medical advisor. He is an energetic physician executive with a passionate focus on health, performance and prevention. Dr. Cherry received emergency medical technician training in the U.S. Navy, a bachelor’s degree in chemistry from Florida State University, medical degree from Nova Southeastern University, and a master’s degree of public health from Uniformed Services University F. Edward Herbert School of Medicine. Dr. Cherry has honed his skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.
Neutra Corp. (OTCQB: NTRR), closed Monday's trading session at $0.00084, up 40.00%, on 18,653,623 volume with 74 trades. The average volume for the last 3 months is 24,529,458 and the stock's 52-week low/high is $0.0006/$0.090000003.
- Neutra Corp. (NTRR) Subsidiary Nearing Market Release of Hemp-Based Sports Cream Expected to be Hit with Amateur and Pro Athletes
- Neutra Corp. (NTRR) Strengthens CBD Retail Market Position with Recent Acquisition
- CBD Popularity Growing with Expanded Wellness & Wellbeing Roles; Neutra Corp. (NTRR) Working to Strengthen Market Position
GP Solutions (OTC: GWPD)
GP Solutions, Inc. (OTC: GWPD) announces today that trading of the Company's common stock on the OTC Pinks is expected to recommence at the opening of the market on October 17, 2019. The SEC had issued a 10-day temporary trading suspension on October 3rd under Section 12(k) of the Exchange Act citing its concerns about (1) the adequacy and reliability of publicly available information concerning the Company, including a certain social media post issued by the Company; and (2) possible manipulative trading in the Company's stock, including certain transactions executed between March 12 and August 27, 2019.
GP Solutions (OTC: GWPD) is developing scalable farming systems for soil-less indoor organic farming. The company’s GrowPods are automated micro-farms that use hydroponic technology and unique soil systems to cultivate the highest-quality specialty leaf crops. The system is designed and engineered for ease of use, allowing users to farm year-round in any location of the world, supporting the company’s mission to provide customers with the ability to cultivate their own organic “superfoods.”
GrowPod Design & Function
GrowPod is a modular, stackable and mobile vertical growing environment specifically engineered to maximize yield and automation. GrowPods are available as a vertical pod, stacker pod or custom-built pod.
The Stacker Pod is a certified organic soil system that offers growers multiple levels of planting in order to maximize space and produce options with different fruits and vegetables. The Vertical Pod utilizes a vertical hydroponic system. It is affordable, scalable, efficient, automated and sustainable. The output provides customers with fresh and clean produce year-round in any climate. The Custom Pod is built to suit the farmer’s specific crop and grow goals.
Each 320-square-foot GrowPod container will have an annual production capability of up to four times that of outdoor growing methods, dramatically increasing profitability to the grower. The controlled environment of the GrowPod ensures efficient power and water usage in growing a wide range of horticultural and agricultural products in all environments and climates.
Thanks to a combination of hydroponic and certified organic soil systems, crop yields are higher, faster, and more consistent that conventional means. Customers can enjoy an average of eight higher yield crop cycles anywhere in the world.
- Modular, stackable and mobile
- Fully insulated, food-grade shipping container
- Engineered for automation
- Efficient LED lighting
- Hydroponic or soil-based platforms
- Proprietary air and water filtration
- Remote monitoring
GP Solutions also offers many services to its customers, including:
- Shipment and installation service of its shipping container farms
- On-site training
- Provision of custom planting and harvesting schedule
- Provision of growing supplies, seeds, nutrients, packaging, branding and repair materials
- On-site visits, on-call and scheduled maintenance, and re-supply
- Remote monitoring and automated control of environmental nutrients, environmental growth factors (PH, temperature, light) and circulation
- Technical assistance
- Consulting and custom facility systems design
GrowPods allow cultivation to take place year-round, which maximizes ROI. The systems are sealed from outside pathogens, contaminants, pesticides, and the result is clean and robust crop production.
GP Solutions also has a line of remarkable new proprietary soil mixtures and nutrient lines which contain no animal products. These products are vital, as many other soils and additives can contain harmful pathogens and contaminants that can cause crops to become tainted or fail rigorous testing.
GP Solutions has partnered with the world’s leading food nonprofit companies, including Feeding America, Seeds of Hope, Habitat for Humanity, Meals on Wheels America, L.A. Kitchen, and Farm Bread, to help insecure communities take control of their own food dependence using container farms.
GP Solutions (GWPD), closed Monday's trading session at $2.15, even for the day, on 29,113 volume. The average volume for the last 3 months is 5,402 and the stock's 52-week low/high is $1.03999996/$21.00.
- GP Solutions, Inc. Trading to Recommence October 17, 2019
- GP Solutions (GWPD) Partners with Snoop Dogg to Co-Brand Innovative Cannabis Growing Solution in Agricultural Heartland
- Coverage Initiated for GP Solutions Inc. via NetworkNewsWire
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF), a leading cannabis branded products company in the U.S., this morning announced the launch of its best-selling gummies* into the Nevada market. According to the update, the products are manufactured through the company’s partnership with TapRoot Holdings Inc., a vertically integrated cannabis company operating cultivation and manufacturing facilities in Las Vegas, Nevada. To view the full press release, visit http://cnw.fm/Q0Ve7.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Monday's trading session at $2.7232, off by 4.9328%, on 35,076 volume with 74 trades. The average volume for the last 3 months is 37,801 and the stock's 52-week low/high is $2.51999998/$6.00810003.
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Announces Launch of Edibles Products into Nevada Adult-Use Cannabis Market
- CBD Isn’t the Fabled Elixir of Youth, But It’s a Lot Closer Than You’d Think
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Launches Nationwide Hemp CBD Product Marketing Campaign
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, today announced that a representative of the company has assumed board positions with three international organizations committed to promote and foster global cannabis industry growth. To view the full press release, visit http://cnw.fm/e3F7l.
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Monday's trading session at $3.22, off by 5.848%, on 1,840,706 volume with 4,984 trades. The average volume for the last 3 months is 1,175,934 and the stock's 52-week low/high is $2.97000002/$8.43999958.
- Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Representative Assumes Board Positions with Organizations Fostering International Cannabis Industry Growth
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Advancing Toward Production Capacity Increase
- Organigram Holdings Inc. CEO Discusses Rampant Growth in Exclusive NetworkNewsWire Broadcast
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was featured today in the 420 with CNW by CannabisNewsWire. On Tuesday, a key Mexican lawmaker introduced a new marijuana legalization bill in parliament. The legislation would allow people to cultivate marijuana in their homes. The coordinator of the ruling MORENA party’s bench in the Deputies Chamber, Mario Delgado Carrillo, while filing the legislation, argued that regulating marijuana would help in promoting health among the Mexicans.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at firstname.lastname@example.org
The Green Organic Dutchman (OTC: TGODF), closed Monday's trading session at $1.38, off by 7.0707%, on 988,783 volume with 949 trades. The average volume for the last 3 months is 721,881 and the stock's 52-week low/high is $1.29999995/$5.2800002.
- 420 with CNW – Another Marijuana Legalization Bill Introduced in Mexico Legislature
- Processing Challenges Could Cause Billions in Losses as Hemp Rots on Farms
- Investment Interest in the Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Rises Following BMO Block Trade
Trxade Group Inc. (TRXD)
Integrated pharmaceutical services company Trxade Group (OTCQB: TRXD) provides pricing analytics for its clients, including smaller, independent pharmacies. To view the full article, visit http://nnw.fm/hi4GY.
Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.
Trxade will leverage and scale its fully integrated model to execute the following growth strategies:
- Increase share of pharmacist drug purchasing
- Additional SKUs and expand product breath
- Partner with Specialty and International Mfg.
- Expand mail order licenses to all 50 states
- Scale Delivmeds for consumer delivery nationwide
- Integration with telemedicine
- M&A Opportunities within drug value chain
Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.
The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.
Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.
Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!
Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.
The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.
Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.
These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.
Health Care Market
The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.
Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.
Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.
TRxADE's programs include:
- TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
- RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
- Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.
Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.
Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.
Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.
Trxade Group Inc. (TRXD), closed Monday's trading session at $1.01, off by 8.1818%, on 1,401 volume with 5 trades. The average volume for the last 3 months is 3,362 and the stock's 52-week low/high is $0.230000004/$1.60000002.
- Trxade Group Inc. (TRXD) Empowers Small, Independent Pharmacies
- Trxade Group Inc. (TRXD) Equipping Community Pharmacies with the Tools Needed to Overcome Their Biggest Challenges
- Tech Solutions Like Those from Trxade Group Inc. (TRXD) Can Help Independent Pharmacies Thrive in the Future
Geyser Brands Inc. (TSX.V: GYSR)
Geyser Brands Inc. (TSX.V: GYSR) was featured today in a publication from HempWireNews, examining how, at the moment, it isn’t legal to grow industrial hemp in Wyoming, but University of Wyoming Extension has released a hemp publication that is intended to give people interested in the crop the latest information so that they can make informed decisions.
Geyser Brands Inc. (TSX.V: GYSR) is a consumer wellness brand cultivator that builds and markets hemp-infused health and wellness products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, baked goods and tincture formulations with superior bioavailability and water solubility. Geyser Brands is rapidly building its revenue-generating operation with a marked milestone in September 2019 with the successful acquisition of Solace Management, a company whose portfolio includes 57 SKUs of consumer wellness goods and pet care products.
Solace recently moved into its new 7,500-square-foot GMP (Good Manufacturing Practices)-compliant facility in Coquitlam, British Columbia, which is expected to trigger up to a 10-fold increase in the company’s production capacity now that it has a Natural Health Product site license from Health Canada. Solace intends to also develop and license new products that are either ready for production or are in various stages of development, since construction of the facility is now complete.
Geyser Brands and Solace welcomed yet another marketable product to their stable with the receipt of an NPN (Natural Product Number) from Health Canada for their hemp-based pain relief roll-on, which means the pain-relief product can now be sold as a natural health product through the company’s Apothecary Naturals line. Health Canada assessed the roll-on and found it to be safe, effective and of high quality when it is used as directed.
The efficacy of most hemp products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.
Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; and provides longer shelf-life and stability of molecules.
Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company’s cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.
Geyser Brands’ integrated production chain and formulation lab develops innovative products using high-quality hemp for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and shelf stability while maintaining all-natural ingredients and ensuring premium quality.
Geyser Brands actively explores opportunities to invest in the research and development of unique, high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.
- Apawthecary Pets – line of products has established itself as leading all-natural hemp-based pet treats with formulations for pet treats, salves and oral drops. Animals, like humans, may suffer from the insomnia, digestive difficulties, pain and inflammation hemp products are designed to relieve a wide variety of conditions. All of Apothecary’s products are made with organic, cold-pressed and unrefined hemp seed oil extract.
- Apothecary Naturals – 100% all-natural, organic, hemp-based topical products for everything from skin care to pain relief.
- WildTails – 100% all-natural, freeze-dried, single-ingredient and nano-hemp infused pet foods and treats.
- Apothecary Ink – Antibacterial skin preparation products, pain control as well as skin care for new and old tattoos.
Chairman and Co-Founder, Brad Kersch, brings a strong business background with over 20 years of experience in successful startups and working with Fortune 500 companies. He spent his early years in the advertising and marketing field and went on to form Hyperware, a clothing company that sold branded clothing to retailers across Canada before selling to clothing giant Ocean Pacific (OP). Kersch became the president of Shoreline Studios, Canada’s largest and oldest studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets.
CEO and Co-Founder, Andreas Thatcher, has been CEO of Geyser Brands since the January 2018 and has been a principal at Rhizome Group since 2014, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media investment company specializing in marketing and distribution financing, and worked in the Investment Banking industry in London and Toronto. Thatcher holds a master’s degree in economics.
CFO Gordon Clissold is a Chartered Professional Accountant with over 20 years of experience as an operational and financial manager for both public and private companies. His career experience spans multiple industries that include technology, manufacturing, wholesale distribution, and professional services. Gordon obtained his accounting designation in 1995, was awarded the Fellowship designation in 2006, and has been awarded life membership as Chartered Professional Accountant.
Kuldip Gill, head of Geyser Brands’ R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill’s experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.
Geyser Brands Inc. (TSX.V: GYSR), closed Monday's trading session at $0.38, off by 7.3171%, on 10,500 volume with 1 trade. The average volume for the last 3 months is 1,982 and the stock's 52-week low/high is $0.360000014/$0.850000023.
- University of Wyoming Releases Hemp Publication
- Geyser Brands Inc. (TSX.V: GYSR) Adds All-Natural, Hemp-Based Pet Treats to Offerings
- Geyser Brands Launches New Premium Brand Line, SToND Naturals
HTC Extraction Systems (TSX.V: HTC)
HTC Extraction Systems (TSX.V: HTC)was featured today in a publication from HempWireNews, Legislative changes and a rapidly increasing demand for CBD products paint a highly optimistic picture for hemp biomass production and extraction companies. Currently, the demand for hemp biomass is exceptionally high, and it is anticipated to remain at such levels through the end of 2019 and into the year to come, reports suggest (http://cnw.fm/HrZU9).
HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.
Advanced Extraction Technologies
For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:
- LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
- PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
- Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.
Delta Purification® Technology
HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:
- Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
- Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
- Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.
Hemp Biomass and Tolling Contracts
HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.
Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.
Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.
The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.
Sales and Offtake Agreements
HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.
HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.
Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.
Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.
HTC Extraction Systems (TSX.V: HTC), closed Monday's trading session at $0.37, off by 11.9048%, on 67,100 volume with 25 trades. The average volume for the last 3 months is 128,820 and the stock's 52-week low/high is $0.079999998/$1.24.
- Market Data Hints at Excellent Opportunities for Hemp Biomass Companies Like HTC Extraction Systems (TSX.V: HTC)
- Solvent-based CO2 Distillation Operation Generates Three-Fold Revenue Hike for HTC Extraction Systems (TSX.V: HTC) Ahead of CBD Strategy
- HTC Extraction Systems (TSX.V: HTC) Achieves Growing Revenues in Q2; Develops CBD FSO Distillate Operation
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) was featured today in a publication from CBDWire, examining how the global hemp-derived CBD oil market reached $591 million in 2018 and is anticipated to grow to $22 billion by 2022 (http://cnw.fm/dTe3n). Wellness and health products are expected to drive this growth as awareness about the benefits of CBD oil continues to increase.
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.
Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.
Gathered within the growing family of Wildflower brands are the following entities:
- Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
- King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
- Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.
Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.
Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.
In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.
Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.
William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.
CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.
Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.
Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.
Wildflower Brands Inc. (WLDFF), closed Monday's trading session at $0.25, off by 10.7143%, on 5,665 volume with 3 trades. The average volume for the last 3 months is 11,533 and the stock's 52-week low/high is $0.221100002/$0.92900002.
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Becoming a CBD Wellness Product Leader as Plant-Based Health Market Explodes
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Has Established Itself as a True Global Supplier of CBD Products
- London Event Discusses CBD Regulation and Safety
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.
Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.
The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.
The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.
The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.
Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.
“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.
In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.
“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.
Petroteq Energy Inc. (PQEFF), closed Monday's trading session at $0.166121, off by 10.6396%, on 83,537 volume with 33 trades. The average volume for the last 3 months is 241,307 and the stock's 52-week low/high is $0.112099997/$0.925000011.
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Resumes Clean Oil Recovery Technology (CORT) Extraction Following Facility Upgrades
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Advancing Toward Expansion Plans
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Announces Commissioning of Asphalt Ridge Facility as Demand Shifts Toward Clean Extraction Tech
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)
As concerns about the safety of vaping products have swept the nation without a clear explanation of what is causing vape-related illnesses, vape manufacturers have found themselves searching for answers, much like the consumers who enjoy their products. On September 27, the U.S. Centers for Disease Control and Prevention acknowledged that the vast majority of the reported vape-related illnesses are linked to cannabis products purchased on the black market instead of from reputable, law-abiding businesses (http://cnw.fm/AFzZ5). IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) addressed the vaporizer concerns in a news release issued September 26, noting the company’s safety standards, its adherence to applicable laws and its desires for a stronger response to black market operations.
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in leading markets across the western United States, with current operations in Washington, Oregon, California and Nevada. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.
With a focus on quality, responsibility and respectability, IONIC’s product lines are pioneering the changing landscape of cannabis consumption. The company’s refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.
IONIC’s Certified Clean program verifies that every product leaving the company’s facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green’s technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package’s QR code with a smartphone camera.
Elite Brand Portfolio/Acquisitions
- IONIC, the company’s flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC’s immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
- WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
- ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
- Vuber Technologies hardware produces the best vaporization experience on the market.
- Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
- Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.
IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.
Experienced Management Team
IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.
Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC’s expansion and development into Washington state’s leading vaporizer brand.
Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.
Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck’s.
Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC’s aggressive sales growth plans across multiple states.
In 2018, IONIC was voted one of the “Top 50 Companies to Work for in Cannabis” by MG Magazine, a publication serving cannabis industry professionals.
IONIC Brands Corp. (OTC: IONKF), closed Monday's trading session at $0.027, off by 10.00%, on 574,807 volume with 88 trades. The average volume for the last 3 months is 282,251 and the stock's 52-week low/high is $0.024399999/$0.634559988.
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Addresses Concerns about Vape Safety, Calls for Stricter Regulation of Black Market
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Secures DTC Eligibility, Gets Greenlight to Trade Shares on Domestic Market
- 420 with CNW – A New Study Aims to Find if Marijuana Can be Used to Treat Symptoms of Autism
CloudCommerce (OTCQB: CLWD)
CloudCommerce Inc. (OTCQB: CLWD) has invested in the development of a suite of proven solutions for businesses needing assistance with marketing, data analysis and web services. The company also provides services such as web design, data analysis and branding, all while leveraging advanced data analysis tools and artificial intelligence.
CloudCommerce (OTCQB: CLWD) is a leading provider of audience-driven business intelligence and marketing solutions. Together with its wholly owned subsidiaries, CloudCommerce delivers invaluable end-to-end business intelligence and marketing solutions through a range of services and capabilities.
SWARM is an end-to-end solution that applies advanced data science, behavioral science, artificial intelligence and market research techniques to deliver powerful audience-driven business intelligence that converts opportunities into business success.
Through marketing, brand perception, customer-relationship management, human-resources management and operational logistics applications, CloudCommerce’s SWARM solution helps businesses determine who to talk to, what to say and how to motivate targeted audiences to take meaningful action.
Marketers have largely taken a blanket approach to communication. The same messages are often sent across an entire customer audience with little regard for how different groups of people communicate, build communities and develop their purchasing habits. When marketers do segment audiences, they use objective selection criteria such as income, geography, education or purchase history to deduce attitudes or intentions.
However, research shows that motivations and feelings are much more accurate at predicting behavior. The challenge for businesses is that these factors are also the hardest to gather from audience data. CloudCommerce provides that audience-intelligent data through SWARM, its proprietary behavioral-science approach to audience creation and communication. Through SWARM, CloudCommerce helps marketers identify consumer motivations and triggers in order to effectively predict and influence actions. When companies influence action, they can change opinions, gather support, motivate purchases and inspire change.
In a fast-developing global business intelligence market estimated to grow from $16.3 billion in 2016 to $34.3 billion by 2022, CloudCommerce stands apart as an innovator and true partner, able to deliver data-driven intelligence and solutions that enable its customers to strengthen their brands, deliver their messages and reach their goals.
THE SWARM—Intelligent Audience Building
The core of the CloudCommerce solution – and what separates CloudCommerce from other audience data companies – is the company’s unique approach to audience building. The concept of “personas” has been around for decades, but CloudCommerce takes that concept to the next level. The SWARM was developed to identify not only who to talk to but also what to say in order to motivate target audiences to take meaningful action. Using CloudCommerce’s proprietary clustering and behavioral analysis techniques, businesses can identify target audiences and deliver messages that are more focused and efficient. CloudCommerce not only helps its client partners find the right people to talk to but also identifies the most powerful message to send.
BUZZ—Behavior-Based Market Research
Market research is evolving. Research techniques developed and used today are more sophisticated and backed by strong data science. Despite these changes, many traditional research firms have failed to innovate: small sample sizes, survey design bias, improper weighting and gut-intuition sampling are just some of the issues that plague the market-research industry. Through BUZZ, CloudCommerce has automated the market research process to provide a level of statistical depth beyond what traditional firms can offer. BUZZ offers businesses the ability to put their finger on the pulse of the marketplace in the moment. Using a wide range of internal and external data sources such as customer data, social media activity, and micro and macro trends, BUZZ deduces attitudes, emotions and opinions.
HIVE—Redefined Geographic Targeting
Conventional geographic audience targeting is outdated. Arbitrary units of location such as counties, cities, DMAs and regions were created centuries ago based on land-rights ownership. Their use in understanding people’s behavior, purchase habits and underlying values is minimal. CloudCommerce has found a much more powerful, efficient and effective way of targeting by clustering people into granular geographic tribes called HIVES. HIVES are defined by attributes such as common language (e.g., colloquialisms), shared experience and narratives (e.g., climate, history), and concentrated demography and biology (e.g., ethnicity, age). Based on the needs of its clients, CloudCommerce can completely redraw the geographic lines based on various Hive selection criteria. Using this exclusive HIVE approach, CloudCommerce clients experience more efficient and effective marketing, make more intelligent business decisions and enjoy more growth.
HONEY—Advanced Reporting and Visualization
Advanced-audience, data-analysis technologies are useless if they don’t produce simple, powerful and actionable business intelligence. HONEY comes with user-friendly reporting and visualization tools to organize and explain all of the advance-data science into a simple-to-understand format for decision makers. HONEY combines the intelligence of client CRM data with third-party consumer data and targeted market research to create a powerful foundation for any audience-intelligence solution.
Data Propria delivers the highest Return on Investment (“ROI”) for their customers’ digital marketing campaigns, by utilizing sophisticated data science to identify the correct universes to target relevant audiences. Their ability to understand and translate data drives every decision they make. By listening to and analyzing their customers’ data they are able to make informed decisions that positively impact their customers’ business. Data Propria leverages industry-best tools to aggregate and visualize data across multiple sources, and then their data and behavioral scientists segment and model that data to be deployed in targeted marketing campaigns. They have data analytics expertise in retail, wholesale, distribution, logistics, manufacturing, political, and several other industries.
Parscale Digital helps their customers get their message out, educate their market and tell their story. They do so creatively and effectively by deploying powerful call-to-action digital campaigns with national reach and boosting exposure and validation with coordinated advertising in print media. Parscale Digital’s fully-developed marketing plans are founded on sound research methodologies, brand audits and exploration of the competitive landscape. Whether their customer is a challenger brand, a political candidate, or a well-known household name, Parscale Digital’s strategists are skilled at leveraging data and creating campaigns that move people to make decisions.
Giles Design Bureau
Giles Design Bureau approaches branding from a “big picture” perspective, establishing a strong identity and then building on that to develop a comprehensive branding program that tells the customer’s story, and articulates what sets the customer apart from their competitors and establishes the customer in their market.
WebTegrity develops commerce-focused, user-friendly digital websites and apps that elevate their customer’s marketing position and draw consumers to their products and services. Their platform-agnostic approach allows WebTegrity to architect and build solutions that are the best fit for each customer. Once the digital properties are built, their experts will help manage and protect the website or app and provide the expertise needed to scale the infrastructure needed as the customer’s business grows.
Andrew Van Noy, CEO & Chairman of CloudCommerce Board of Directors
Andrew Van Noy has been a director of CloudCommerce since November 2012, president of the company since April 2012, and the CEO of the company since August 2012. He also served as executive vice president of CloudCommerce from November 2011 to April 2012 and vice president of Sales and Marketing of the company from May 2011 to November 2011. From January 2009 to April 2011, Van Noy served as the vice president of Sales and Marketing for PageTransformer, which provided web and software development for iPad, iPhone and Android devices. Van Noy came to CloudCommerce with experience in digital marketing, private equity and investment banking. During his years at the company, Van Noy led the efforts to rebrand and restructure the business and presided over the acquisition of a number of companies. Van Noy graduated from BYU with a Bachelor of Science degree.
Gregory Boden, CFO and Board of Directors
Gregory Boden became a director at CloudCommerce in November 2011 and in February 2013 was named corporate secretary. In April 2012, Boden was also appointed CFO. In addition, Boden is the managing partner of a private equity company. Prior to joining the CloudCommerce team, Boden managed the franchise accounting and cash application departments of Select Staffing, a nationwide staffing company and was an accountant at KPMG LLP. Boden earned his master of accountancy degree from the University of Denver.
Brad Parscale, Board of Directors
Brad Parscale creates web-marketing strategies and oversees all technical and functional aspects of these strategies. Originally from Kansas, Parscale spent five years in California before moving to San Antonio in 2004 to establish Parscale Media, a successful web-marketing firm. His 2011 partnership with Jill Giles formed Giles-Parscale Inc. In 2016, Parscale was named digital director for the Donald J. Trump presidential campaign.
Zachary Bartlett, VP of Corporate Development and Board of Directors
Zachary Bartlett has been a director of the company since July 2012 and was appointed vice president of Corporate Development in January 2018. Bartlett has also served as vice president of Communications and an independent contractor assisting with project management matters. Prior to joining CloudCommerce, Bartlett was the creative director at Crowbar Studios Inc., a graphic design and web development firm he founded in 2008. From 2004 to 2008, he held the position of art and brand consultant at Demon International, a snowboard accessories company. Bartlett earned his bachelor of fine arts degree in graphic design from Brigham Young University.
CloudCommerce (OTCQB: CLWD), closed Monday's trading session at $0.00346, off by 2.5352%, on 49,961 volume with 2 trades. The average volume for the last 3 months is 1,033,665 and the stock's 52-week low/high is $0.0027/$0.0228.
- CloudCommerce Inc. (CLWD) Positioned as Premier Solution Provider for Business Marketing Sector
- CloudCommerce Inc.’s (CLWD) Flagship Solution Uses AI to Identify New Customers
- CloudCommerce Inc. (CLWD) Discusses Innovation and Strategy in Exclusive Audio Interview
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) B2 Fighting Series Continues with Pinnacle Combat Event, HRMMA CEO Receives Lifetime Achievement Award
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Opens Learning Center Featuring Augmented Reality Games, Educational Content
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) 420 with CNW – FBI Data Shows Cannabis Arrests Increased Last Year
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) First Pick-Your-Own Hemp Garden Opens in Maine
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Voices Support of SAFE Banking Act
- ChineseInvestors.com (CIIX) Positioned as First Company to Market CBD Products to Chinese-Speaking Consumers
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Names New CFO; Announces Private Placement, Equity Issuances
- CloudCommerce (OTCQB: CLWD) Flagship Solution Uses AI to Identify New Customers
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Earth Science Tech, Inc. (ETST) Hygee Home Kit Playing Key Role in Fight Against STIs and Undiagnosed Cases
- Endonovo Therapeutics (OTCQB: ENDV) Appoints Recognized Medical Professional and Business Visionary Dr. William Li as Strategic Advisor to the CEO
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Enters Strategic Agreement with Leading Chinese Infrared Camera Manufacturer
- Genprex, Inc. (NASDAQ: GNPX) Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers
- Geyser Brands Inc. (TSX.V: GYSR) Adds All-Natural, Hemp-Based Pet Treats to Offerings
- GP Solutions (GWPD) Partners with Snoop Dogg to Co-Brand Innovative Cannabis Growing Solution in Agricultural Heartland
- Grapefruit Boulevard Investments Inc. (IGNG) 420 with CNW – Cannabis Expo in West Michigan Set to Educate Consumers and Businesses about the Marijuana Industry
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Opens 150th CBD Shop and Provides Progress Update
- Green Hygienics Holdings Inc. (GRYN) 420 with CNW – The Benefits of Marijuana During Breast Cancer Treatment
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- HTC Extraction Systems (TSX.V: HTC) Solvent-based CO2 Distillation Operation Generates Three-Fold Revenue Hike for HTC Extraction Systems Ahead of CBD Strategy
- INmune Bio, Inc. (NASDAQ: INMB) CEO Discusses Company Achievements in Interview; Director of Neuroscience to Present at World Immunotherapy Congress
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Secures DTC Eligibility, Gets Greenlight to Trade Shares on Domestic Market
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Global CBD Prices Reduce as US Supply Shakes the Market
- Marijuana Company of America Inc. (MCOA) Global CBD Prices Reduce as US Supply Shakes the Market
- MustGrow Biologics Corp (CSE: MGRO) Outlines Portfolio of Natural Bio-Pesticides and Bio-Fertility Products
- Neutra Corp. (OTCQB: NTRR) Strengthens CBD Retail Market Position with Recent Acquisition
- Nightfood, Inc. (OTCQB: NGTF) Reports Record Quarterly Revenues, Data Indicating Steadily Increasing Same Store Sales
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Advancing Toward Production Capacity Increase
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Ongoing Drill Results Confirm Significant, Near Surface Cobalt and Nickel Mineralization
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Advancing Toward Expansion Plans
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) CBD Isn’t the Fabled Elixir of Youth, But It’s a Lot Closer Than You’d Think
- Predictive Oncology Inc. (NASDAQ: POAI) Sells 10 STREAMWAY® Systems to Prominent Teaching Hospital
- Pressure BioSciences Inc. (PBIO) Zacks Small Cap Research Initiates Coverage on Pressure BioSciences, Inc.
- Quest Patent Research Corp. (QPRC) Holds Broad Portfolio of Intellectual Property Assets
- Sharing Services Global Corporation (SHRG) Focuses on International Expansion
- SinglePoint, Inc. (SING) CEO Reports from NACS Tradeshow on MoneyTV with Donald Baillargeon
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Leading Taxi Technology Distributor Increases Purchase Order to Over $850,000
- Spectrum Global Solutions, Inc. (SGSI) Secures $3.3 Million in New Contract Awards
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Announces Expansion With New Manufacturing Facility
- SRAX Inc. (NASDAQ: SRAX) Showcases Company Presentation at Leading Consumer & Media Conference, Reviews Impressive Growth
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) CEO to Participate at September 17 Battery Next Summit in Boulder, CO
- Sugarmade, Inc. (SGMD) CBD Isn’t the Fabled Elixir of Youth, But It’s a Lot Closer Than You’d Think
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Posts Record Quarter-End, Year-End Numbers
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Processing Challenges Could Cause Billions in Losses as Hemp Rots on Farms
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Processing Challenges Could Cause Billions in Losses as Hemp Rots on Farms
- Trxade Group Inc. (TRXD) Equipping Community Pharmacies with the Tools Needed to Overcome Their Biggest Challenges
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Reaffirms Timing of First Harvest at Kimmetts and Additional 2020 Cultivation Plans
- VPR Brands, LP (VPRB) Offers Robust Suite of Products in Nicotine, CBD Verticals
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Has Established Itself as a True Global Supplier of CBD Products
- Willow Biosciences Inc. (CSE: WLLW) London Event Discusses CBD Regulation and Safety
- Xalles Holdings Inc. (XALL) Building Fintech Support Strategy Through Acquisitions, Mentoring
- Youngevity International, Inc. (NASDAQ: YGYI) Announces Dividend Payment Timing for September 2019 Series “D” Cumulative Redeemable Perpetual Preferred Stock
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.